VC-backed TransMedics debuts IPO
Andover, Massachusetts-based TransMedics, a medical technology company, has raised over $91 million for its IPO after pricing its nearly 5.7 million shares at $16 per share. The stock began trading May 2, 2019 on the NASDAQ under the ticker symbol "TMDX." Morgan Stanley and J.P. Morgan are the lead underwriters. The company's pre-IPO backers include Flagship Pioneering and Kleiner Perkins.
2 May 2019•2 mins read
